Cargando…

Incidence and Risk Factors of Serious Adverse Events during Antituberculous Treatment in Rwanda: A Prospective Cohort Study

BACKGROUND: Tuberculosis (TB) and TB-human immunodeficiency virus infection (HIV) coinfection is a major public health concern in resource-limited settings. Although TB treatment is challenging in HIV-infected patients because of treatment interactions, immunopathological reactions, and concurrent i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lorent, Natalie, Sebatunzi, Osee, Mukeshimana, Gloria, Van den Ende, Jef, Clerinx, Joannes
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097195/ https://www.ncbi.nlm.nih.gov/pubmed/21611117 http://dx.doi.org/10.1371/journal.pone.0019566

Ejemplares similares

Effectiveness and Safety of Concurrent Use of First-Line Antiretroviral and Antituberculous Drugs in Rwanda
por: Kadima, Justin Ntokamunda, et al.
Publicado: (2014)

Hepatitis B vaccination coverage among healthcare workers at a tertiary hospital in Rwanda
por: Muvunyi, Claude Mambo, et al.
Publicado: (2018)

Knowledge and attitudes towards antibiotic use and resistance among undergraduate healthcare students at University of Rwanda
por: Nisabwe, Lyduine, et al.
Publicado: (2020)

Antituberculous Serum
Publicado: (1899)

On Treatment with Antituberculous Serum
Publicado: (1904)

Management of Co-Morbidity of Depression and Chronic Non-Communicable Diseases in Rwanda
por: Mukeshimana, Madeleine, et al.
Publicado: (2017)

Depression and Associated Factors Among the Patients with Type 2 Diabetes in Rwanda
por: Mukeshimana, Madeleine, et al.
Publicado: (2019)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Impact of immunopathology on the antituberculous activity of pyrazinamide
por: Blanc, Landry, et al.
Publicado: (2018)

Serious Neurological Adverse Events of Ceftriaxone
por: Lacroix, Clémence, et al.
Publicado: (2021)

Paradoxical Tuberculomas after Completion of Antituberculous Treatment
por: Shah, Ira, et al.
Publicado: (2012)

AdDRESSing T-cell responses to antituberculous drugs
por: Pavlos, R., et al.
Publicado: (2017)

Renal BCGosis managed conservatively with antituberculous medications
por: Elmekresh, Amr, et al.
Publicado: (2023)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

A prospective study of antituberculous drug-induced hepatotoxicity in an area endemic for liver diseases
por: Makhlouf, Hoda A., et al.
Publicado: (2008)

Incidence of Ipilimumab-Related Serious Adverse Events in Patients with Advanced Cancer: A Meta-Analysis
por: Guo, Chang-Ying, et al.
Publicado: (2019)

ANTITUBERCULOUS IMMUNITY IN MICE VACCINATED WITH KILLED TUBERCLE BACILLI
por: Dubos, René J., et al.
Publicado: (1953)

Tuberculosis associated thrombocytopenic purpura: effectiveness of antituberculous therapy
por: Borie, Raphael, et al.
Publicado: (2009)

Early monitoring for detection of antituberculous drug-induced hepatotoxicity
por: Lee, Chang Min, et al.
Publicado: (2016)

Lansoprazole is an antituberculous prodrug targeting cytochrome bc(1)
por: Rybniker, Jan, et al.
Publicado: (2015)

Management of Severe Gastrointestinal Tuberculosis with Injectable Antituberculous Drugs
por: Goldani, Luciano Z., et al.
Publicado: (2015)

Serious adverse events associated with yellow fever vaccine
por: de Menezes Martins, Reinaldo, et al.
Publicado: (2015)

Analysis of serious adverse event: Writing a narrative
por: Nambiar, Indu
Publicado: (2018)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Immunotherapeutic role of Ag85B as an adjunct to antituberculous chemotherapy
por: Sheikh, Javaid A, et al.
Publicado: (2011)

A Newly Developed Pericardial Tuberculoma During Antituberculous Therapy
por: Kim, Sang Min, et al.
Publicado: (2011)

CONTRA-LATERAL PARADOXICAL PLEURAL EFFUSION DURING ANTITUBERCULOUS CHEMOTHERAPY
por: Chopra, Vishal, et al.
Publicado: (2008)

Long-acting antituberculous therapeutic nanoparticles target macrophage endosomes
por: Edagwa, Benson J., et al.
Publicado: (2014)

Clinical picture and outcome of Serious Adverse Events in the treatment of Onchocerciasis
por: Awadzi, Kwablah
Publicado: (2003)

Influenza Vaccination of Pregnant Women and Serious Adverse Events in the Offspring
por: Donzelli, Alberto
Publicado: (2019)

A rare case of unilateral gynecomastia during antituberculous chemotherapy with isoniazid
por: Goud, B. K. Manjunatha, et al.
Publicado: (2012)

Surveillance of serious adverse events following immunization in resource poor settings
por: Breugelmans, Gabrielle J, et al.
Publicado: (2011)

Antipsychotics-Associated Serious Adverse Events in Children: An Analysis of the FAERS Database
por: Kimura, Goji, et al.
Publicado: (2015)

A Cancer Patient’s Experience With a Rare But Serious Adverse Event
por: RayChaudhury, Amlan
Publicado: (2019)

An HIV-infected Patient with No Serious Adverse Events after Overdosing on Raltegravir
por: Hosoda, Tomohiro, et al.
Publicado: (2019)

Serious Adverse Drug Events Reported to the FDA: Analysis of the FDA Adverse Event Reporting System 2006-2014 Database
por: Sonawane, Kalyani B., et al.
Publicado: (2018)

ANTITUBERCULOUS IMMUNITY INDUCED BY METHANOL EXTRACTS OF TUBERCLE BACILLI—ITS ENHANCEMENT BY ADJUVANTS
por: Weiss, David W., et al.
Publicado: (1956)

ANTITUBERCULOUS IMMUNITY INDUCED IN MICE BY VACCINATION WITH LIVING CULTURES OF ATTENUATED TUBERCLE BACILLI
por: Dubos, René J., et al.
Publicado: (1953)

Hair Analysis for Determination of Isoniazid Concentrations and Acetylator Phenotype during Antituberculous Treatment
por: Eisenhut, Michael, et al.
Publicado: (2012)

Effective antituberculous therapy in a patient with CLIPPERS: New insights into CLIPPERS pathogenesis
por: Mélé, Nicolas, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_g6pgl7tqqa9m055lkfcuncdu53